| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |